What's in Biomed Industries, Inc.'s pipeline?

Biomed Industries, Inc. has 9 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 5 in Phase 2, 0 in Phase 1.

Which companies overlap with Biomed Industries, Inc.'s portfolio?

Top competitors by shared drug class: Merck Sharp & Dohme LLC, AstraZeneca, GlaxoSmithKline, Jean-Pierre Van geertruyden, Sanofi.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/biomed-industries-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Biomed Industries, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biomed Industries, Inc. pipeline: 0 marketed, 0 filed, 4 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 5 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
NA-831	NA-831	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
Biological: oral polio vaccine	Biological: oral polio vaccine	phase 3	Live attenuated viral vaccine	Poliovirus types 1, 2, and 3	Immunology / Infectious Disease
Comparable Placebo of drug	Comparable Placebo of drug	phase 3
Bionetide	Bionetide	phase 3			Other

Therapeutic area mix

Diabetes · 2
Immunology / Infectious Disease · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Merck Sharp & Dohme LLC · 2 shared drug classes
AstraZeneca · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Jean-Pierre Van geertruyden · 2 shared drug classes
Sanofi · 2 shared drug classes
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Biomed Industries, Inc.:

Cite this brief

Drug Landscape (2026). Biomed Industries, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biomed-industries-inc. Accessed 2026-05-17.